Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder

BJU Int. 2007 Apr;99(4):831-5. doi: 10.1111/j.1464-410X.2006.06735.x. Epub 2007 Jan 22.

Abstract

Objectives: To elucidate, in patients with benign prostatic hyperplasia (BPH), how often detrusor overactivity (DOA) is persistent after transurethral resection of the prostate (TURP) and if perfusion of the lower urinary tract influences postoperative outcomes.

Patients and methods: Fifty men with urodynamically confirmed DOA and bladder outlet obstruction due to BPH had a TURP. Before and 1 year after TURP the International Prostate Symptom Score (IPSS), quality of life (QoL) score, prostate-specific antigen (PSA) level and total prostatic volume (TPV) were evaluated. Also, the lower urinary tract was evaluated using pressure-flow studies and transrectal colour Doppler ultrasonography to assess the vascular resistive index (RI) as a variable of the perfusion of the lower urinary tract.

Results: After TURP the IPSS, QoL score, PSA level and TPV decreased. Cystometric measurements showed that in 15 (30%) patients DOA was persistent after TURP. The mean (sd) maximum urinary flow rate increased from 9.20 (4.03) to 15.98 (4.62) mL/s and postvoiding residual urine volumes decreased from 109.38 (73.71) to 29.24 (45.00) mL. When men with persistent DOA (15 patients; group 1) were compared with those with no DOA after TURP (35; group 2) there was a statistically significantly higher RI of the bladder vessels in group 1, at 0.86 (0.068) than in group 2, at 0.68 ( 0.055) (P < 0.001).

Conclusions: Persistent DOA in men after TURP seems to be associated with increased vascular resistance of the bladder vessels with subsequent reduced perfusion and hypoxia.

MeSH terms

  • Aged
  • Humans
  • Male
  • Prostate-Specific Antigen / blood
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / physiopathology
  • Prostatic Hyperplasia / surgery*
  • Quality of Life
  • Transurethral Resection of Prostate*
  • Treatment Outcome
  • Ultrasonography
  • Urinary Bladder, Overactive / etiology*
  • Urinary Bladder, Overactive / physiopathology
  • Urinary Tract / blood supply*
  • Urinary Tract / diagnostic imaging
  • Urodynamics

Substances

  • Prostate-Specific Antigen